Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN
Portfolio Pulse from
Levi & Korsinsky has announced a lead plaintiff deadline of March 10, 2025, for a lawsuit involving Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Shareholders who suffered losses are encouraged to seek potential recovery under federal securities laws.
February 21, 2025 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a lawsuit with a lead plaintiff deadline of March 10, 2025. Shareholders who incurred losses are advised to consider potential recovery options.
The announcement of a lawsuit and a lead plaintiff deadline suggests potential legal challenges for Regeneron Pharmaceuticals. This could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100